Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model.

Source:http://linkedlifedata.com/resource/pubmed/id/21407223

Br. J. Cancer 2011 Mar 15 104 6 941-7

Download in:

View as

General Info

PMID
21407223